Knowledge bases and software support for variant interpretation in precision oncology
- PMID: 33971666
- PMCID: PMC8574624
- DOI: 10.1093/bib/bbab134
Knowledge bases and software support for variant interpretation in precision oncology
Erratum in
-
Knowledge bases and software support for variant interpretation in precision oncology.Brief Bioinform. 2021 Nov 5;22(6):bbab246. doi: 10.1093/bib/bbab246. Brief Bioinform. 2021. PMID: 34125166 Free PMC article. No abstract available.
Abstract
Precision oncology is a rapidly evolving interdisciplinary medical specialty. Comprehensive cancer panels are becoming increasingly available at pathology departments worldwide, creating the urgent need for scalable cancer variant annotation and molecularly informed treatment recommendations. A wealth of mainly academia-driven knowledge bases calls for software tools supporting the multi-step diagnostic process. We derive a comprehensive list of knowledge bases relevant for variant interpretation by a review of existing literature followed by a survey among medical experts from university hospitals in Germany. In addition, we review cancer variant interpretation tools, which integrate multiple knowledge bases. We categorize the knowledge bases along the diagnostic process in precision oncology and analyze programmatic access options as well as the integration of knowledge bases into software tools. The most commonly used knowledge bases provide good programmatic access options and have been integrated into a range of software tools. For the wider set of knowledge bases, access options vary across different parts of the diagnostic process. Programmatic access is limited for information regarding clinical classifications of variants and for therapy recommendations. The main issue for databases used for biological classification of pathogenic variants and pathway context information is the lack of standardized interfaces. There is no single cancer variant interpretation tool that integrates all identified knowledge bases. Specialized tools are available and need to be further developed for different steps in the diagnostic process.
Keywords: HiGHmed; cancer therapy; data integration; molecular tumor board; personalized medicine.
© The Author(s) 2021. Published by Oxford University Press.
Figures


Similar articles
-
CIViCpy: A Python Software Development and Analysis Toolkit for the CIViC Knowledgebase.JCO Clin Cancer Inform. 2020 Mar;4:245-253. doi: 10.1200/CCI.19.00127. JCO Clin Cancer Inform. 2020. PMID: 32191543 Free PMC article.
-
DrugCVar: a platform for evidence-based drug annotation for genetic variants in cancer.Bioinformatics. 2022 May 26;38(11):3094-3098. doi: 10.1093/bioinformatics/btac273. Bioinformatics. 2022. PMID: 35426945
-
Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants.Genome Med. 2019 Aug 23;11(1):53. doi: 10.1186/s13073-019-0664-4. Genome Med. 2019. PMID: 31443733 Free PMC article.
-
Practice innovation: the need for nimble data platforms to implement precision oncology care.Discov Med. 2015 Jul-Aug;20(108):27-32. Discov Med. 2015. PMID: 26321084 Review.
-
Pharmacogenomics knowledge for personalized medicine.Clin Pharmacol Ther. 2012 Oct;92(4):414-7. doi: 10.1038/clpt.2012.96. Clin Pharmacol Ther. 2012. PMID: 22992668 Free PMC article. Review.
Cited by
-
High-precision information retrieval for rapid clinical guideline updates.NPJ Digit Med. 2025 Apr 27;8(1):227. doi: 10.1038/s41746-025-01648-5. NPJ Digit Med. 2025. PMID: 40289217 Free PMC article.
-
Unveiling the Digital Evolution of Molecular Tumor Boards.Target Oncol. 2025 Jan;20(1):27-43. doi: 10.1007/s11523-024-01109-1. Epub 2024 Nov 28. Target Oncol. 2025. PMID: 39609355 Free PMC article. Review.
References
-
- Horak P, Klink B, Heining C, et al. Precision oncology based on omics data: the NCT Heidelberg experience. Int J Cancer 2017. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical